EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual-Therapy Resorbable Biomaterials to Eliminate Bone Infections and Biofilms

Luiza DaMotta iD, Andrés J García iD

ACS Applied Bio Materials · 11.11.2026

DOI: 10.1021/acsabm.6c01493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 11.11.2026. Verfasst von Luiza DaMotta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia30332, USA. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthopedic implants can become infected in hospitals requiring additional surgeries and device replacement. The pathogenesis of these device-associated bone infections is fundamentally driven by the transition of opportunistic pathogens from a free-floating planktonic state to a surface-bound, highly resilient biofilm state. Biofilms shield resident bacteria within a self-secreted extracellular polymeric substance (EPS) matrix, making them up to 1000-fold more resistant to conventional systemic antibiotics and host-immune clearance. To overcome the clinical challenges of biofilm elimination, the field of regenerative bone biointerfaces is transitioning from traditional antibiotic therapies toward multifunctional, fully resorbable, dual-therapy biomaterial platforms. These modern architectures are engineered to simultaneously clear localized infections and orchestrate host bone tissue reconstruction within a single surgical window. This review provides a comprehensive categorization and critical evaluation of six breakthrough therapeutic themes shaping next-generation orthopedic scaffolds: (1) spatiotemporally optimized dual or multiple antibiotic delivery networks; (2) integrated antibiotic–osteogenic growth factor/peptide frameworks; (3) mechanistically direct biofilm matrix-disrupting enzyme matrices; (4) localized hyperthermic near-infrared (NIR) photothermal therapy combined with osteogenic scaffolds; (5) intrinsic antibiotic-free antimicrobial metal ion/nanoparticle scaffolds; and (6) alternative biological agent architectures leveraging bacteriophages or probiotic biofilms. This review summarizes the advantages, limitations, clinical potential, and future research directions of each therapeutic platform.

Schlagwörter

Stichwörter der Autor:innen

antimicrobialbiofilmbone defectimplantable biomaterialslocal deliveryorthopedic infection

Autor:innen und Institutionen

  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia30332, USA.
  • Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia30332, USA.
  • Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia30332, USA.

ORCID-Profile: Luiza DaMotta, Andrés J García

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

DaMotta, L., & García, A. J. (2026). Dual-Therapy Resorbable Biomaterials to Eliminate Bone Infections and Biofilms. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01493

Vancouver

DaMotta L, García AJ. Dual-Therapy Resorbable Biomaterials to Eliminate Bone Infections and Biofilms. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01493

BibTeX
@article{DaMotta2026,
  author = {DaMotta, Luiza and García, Andrés J},
  title = {Dual-Therapy Resorbable Biomaterials to Eliminate Bone Infections and Biofilms},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c01493}
}
Kostenlos starten →